News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
656,372 Results
Type
Article (33239)
Company Profile (689)
Press Release (622444)
Section
Business (202882)
Career Advice (2168)
Deals (37121)
Drug Delivery (96)
Drug Development (80387)
Employer Resources (165)
FDA (15657)
Job Trends (14969)
News (343151)
Policy (30180)
Tag
Academia (1321)
Alliances (48569)
Alzheimer's disease (1167)
Approvals (15573)
Artificial intelligence (125)
Bankruptcy (369)
Best Places to Work (10922)
Biotechnology (472)
Breast cancer (99)
Cancer (916)
Career advice (1788)
Cell therapy (217)
Clinical research (64137)
Collaboration (342)
Compensation (173)
COVID-19 (2169)
C-suite (94)
Data (915)
Diabetes (135)
Diagnostics (6123)
Drug pricing (84)
Earnings (83436)
Employer resources (142)
Events (109335)
Executive appointments (265)
FDA (16094)
Funding (296)
Gene therapy (152)
GLP-1 (599)
Government (2981)
Healthcare (15929)
Infectious disease (2245)
Inflammatory bowel disease (104)
Interviews (429)
IPO (17113)
Job creations (4407)
Job search strategy (1500)
Layoffs (472)
Legal (7628)
Lung cancer (152)
Manufacturing (175)
Medical device (13366)
Medtech (13371)
Mergers & acquisitions (20032)
Metabolic disorders (386)
Neuroscience (1424)
NextGen Class of 2024 (6019)
Non-profit (2029)
Northern California (1306)
Obesity (227)
Opinion (224)
Patents (99)
People (56831)
Pharmaceutical (137)
Phase I (19988)
Phase II (28539)
Phase III (21277)
Pipeline (322)
Postmarket research (2133)
Preclinical (8180)
Radiopharmaceuticals (249)
Rare diseases (194)
Real estate (6007)
Regulatory (20718)
Research institute (1384)
Resumes & cover letters (341)
Southern California (1162)
Startups (3920)
United States (12502)
Vaccines (520)
Weight loss (180)
Date
Today (229)
Last 7 days (1080)
Last 30 days (3344)
Last 365 days (36339)
2024 (31944)
2023 (40680)
2022 (51209)
2021 (54624)
2020 (51618)
2019 (42541)
2018 (32491)
2017 (33100)
2016 (31449)
2015 (36931)
2014 (30151)
2013 (25283)
2012 (26866)
2011 (27027)
2010 (25023)
Location
Africa (692)
Arizona (134)
Asia (42088)
Australia (6716)
California (3050)
Canada (1203)
China (226)
Colorado (129)
Connecticut (135)
Europe (88172)
Florida (379)
Georgia (102)
Illinois (274)
Indiana (198)
Kansas (93)
Maryland (484)
Massachusetts (2561)
Michigan (161)
Minnesota (264)
New Jersey (881)
New York (876)
North Carolina (763)
Northern California (1306)
Ohio (118)
Pennsylvania (763)
South America (1092)
Southern California (1162)
Texas (426)
Washington State (356)
656,372 Results for "taiho pharmaceutical company ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Taiho Oncology to Present Data at the 66th American Society of Hematology Annual Meeting
November 5, 2024
·
3 min read
Biotech Bay
Taiho Ventures Expands Investment Pool to $400 Million to Continue Quality Investments and Accelerate Open Innovation
Taiho Pharmaceutical Co., Ltd. and Taiho Ventures, LLC, a strategic corporate venture capital arm of Taiho Pharmaceutical, announced that Taiho Ventures has increased its investment pool by $100 million from $300 million to $400 million.
January 8, 2024
·
2 min read
Business
Araris Biotech AG Announces Research Collaboration with Taiho Pharmaceutical to Develop Next-Generation ADCs Using Araris’ Proprietary Linker-Conjugation Technology
Araris Biotech AG announced they have entered a collaboration agreement under which Araris will use its proprietary linker-conjugation platform to generate novel ADCs against undisclosed targets provided by Taiho Pharmaceutical Co., Ltd., a Japanese R&D-driven specialty pharma company with a focus on oncology.
November 8, 2023
·
1 min read
Biotech Bay
Taiho Oncology and Astex Pharmaceuticals Announce Data Presentations at the 65th ASH Annual Meeting
Taiho Oncology Inc. and Astex Pharmaceuticals, Inc. announced today details of studies to be presented at the 65th American Society of Hematology (ASH) Annual Meeting, to be held Dec. 9-12, 2023, in San Diego.
November 17, 2023
·
5 min read
Business
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
Verrica Pharmaceuticals Inc. today announced that it has entered into an amendment to its existing licensing agreement with Torii Pharmaceutical Co. Ltd. (Torii), to jointly conduct a global pivotal Phase 3 clinical trial of YCANTH® for the treatment of common warts.
May 15, 2024
·
9 min read
Press Releases
NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
October 28, 2024
·
1 min read
BioCapital
Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.
Vanda Pharmaceuticals Inc. confirmed that it has received an unsolicited, non-binding indication of interest from Cycle Group Holdings Ltd. to acquire the Company for $8.00 per share in cash.
June 6, 2024
·
3 min read
Pharm Country
Taiho Oncology Announces Presentation of Data From a U.S. Real-Word Study of Oral Decitabine and Cedazuridine
Taiho Oncology, Inc. announced results of a U.S. real-world study of oral decitabine and cedazuridine in patients with myelodysplastic syndromes, a rare form of blood cancer.
December 10, 2023
·
6 min read
Drug Development
Taiho Oncology Announces Publication of Final Results of the Phase 3 ASCERTAIN Clinical Trial of Oral Decitabine and Cedazuridine Fixed Dose Combination (INQOVI®) in Patients With MDS and CMML
Taiho Oncology, Inc. announces publication of the final results from the pivotal ASCERTAIN clinical trial of fixed-dose oral decitabine and cedazuridine (INQOVI®) compared to intravenous decitabine in adults with intermediate and high-risk myelodysplastic syndromes (MDS) including chronic myelomonocytic leukemia (CMML).
January 23, 2024
·
11 min read
Press Releases
NLS Pharmaceutics Ltd. Announces Closing of Private Placement and Expected Compliance with Nasdaq Continued Listing Rules
October 15, 2024
·
4 min read
1 of 65,638
Next
